Details of the Drug Formulaction

General Information of Drug Formulation (ID: F16191)

• Formulation Name: Oxybutynin 5 mg tablet
• Company: Cadila Healthcare; Zydus Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Oxybutynine	(DMJPBAX)	Obsolete neurogenic bladder		Investigative

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Triethyl citrate	(E00128)	6506	Plasticizing agent; Solvent